Publication date:
15 April 2026
Last updated:
Advice sent to the Minister of Health in February 2026 is listed below, along with links to any documents that have been proactively released.
| Date Sent | Reference | Title |
|---|---|---|
| 2/02/2026 | H2026077513 | Withheld under s9(2)(f)(iv) of the Official Information Act |
| 3/02/2026 | H2026077819 | Waitangi Day attendance |
| 4/02/2026 | H2026077596 | Quarterly meeting with the Hauora Māori Advisory Committee on 10 February 2026 |
| 4/02/2026 | H2026077439 | Update on costs to support implementation of an administrative data census model |
| 4/02/2026 | H2025075825 | Government response to the Petition to release the Pfizer COVID-19 vaccine contract |
| 4/02/2026 | H2026078056 | Budget 2026 Vote Health Bilateral Pre-Meeting |
| 4/02/2026 | H2025070442 | Enhancing assessment and management of neurodevelopmental conditions in children |
| 5/02/2026 | H2026077422 | Withheld under s9(2)(f)(iv) of the Official Information Act |
| 5/02/2026 | H2026078049 | Withheld under s9(2)(f)(iv) of the Official Information Act |
| 5/02/2026 | H2026077639 | Withheld under s9(2)(f)(iv) of the Official Information Act |
| 10/02/2026 | H2026077470 | Withheld under s9(2)(f)(iv) of the Official Information Act |
| 10/02/2026 | H2026078233 | Meeting with BioOra |
| 10/02/2026 | H2026078489 | Meeting with Christchurch Cancer Foundation |
| 11/02/2026 | H2026077645 | Withheld under s9(2)(f)(iv) of the Official Information Act |
| 12/02/2026 | H2026077342 | 2026 March Baseline Update Submission for Vote Health |
| 12/02/2026 | H2026077414 | Withheld under s9(2)(f)(iv) of the Official Information Act |
| 12/02/2026 | H2026078163 | Health New Zealand monthly report – November and December 2025 |
| 12/02/2026 | H2025077125 | Withheld under s9(2)(f)(iv) of the Official Information Act |
| 12/02/2026 | H2026078160 | Options on progressing genomics in New Zealand |
| 12/02/2026 | H2026078231 | Withheld under s9(2)(f)(iv) of the Official Information Act |
| 13/02/2026 | H2025076581 | Revised approval process for the Nelson Hospital Redevelopment |
| 13/02/2026 | H2026077832 | Social Investment Ministers Group meeting Tuesday 17 Feb 2026 |
| 13/02/2026 | H2026077550 | Transfer of funding and purchasing responsibility for ambulance medicines |
| 16/02/2026 | H2025077094 | Meeting with the Calvin Chua Philanthropic Trust |
| 16/02/2026 | H2026077539 | Meeting with Pharmaceutical Society Of New Zealand |
| 16/02/2026 | H2025077198 | Meeting with Pharmacy Council |
| 17/02/2026 | H2026077466 | Cover briefing Amendment to Health Capital Settings |
| 18/02/2026 | H2025076356 | Government response to the Petitions Committee report – nationwide regulations and standards for laser tattoo removal |
| 18/02/2026 | H2026078166 | Controlled drugs stocktake requirement in Misuse of Drugs Regulations |
| 19/02/2026 | H2026077822 | Withheld under s9(2)(f)(iv) of the Official Information Act |
| 19/02/2026 | H2025075632 | Withheld under s9(2)(f)(iv) of the Official Information Act |
| 19/02/2026 | H2025075245 | Meeting with the Breast Cancer Foundation NZ |
| 20/02/2026 | H2026078018 | Primary Care Health Target – update on implementation planning |
| 20/02/2026 | H2026078597 | Advice on community-based obstetric ultrasounds |
| 20/02/2026 | H2026077446 | Withheld under s9(2)(f)(iv) of the Official Information Act |
| 20/02/2026 | H2026078645 | Options to restrict usage of nitrous oxide |
| 25/02/2026 | H2026077324 | Withheld under s9(2)(f)(iv) of the Official Information Act |
| 26/02/2026 | H2026078620 | 2026/27 Draft Letters of Expectation for the Health and Disability Commissioner, the Health Quality and Safety Commission, the Health Research Council of New Zealand and New Zealand Blood and Organ Service |
| 26/02/2026 | H2026078858 | Update on the Budget 2024 funding allocations for COVID-19 and Pandemic Preparedness |
| 26/02/2026 | H2026078230 | Withheld under s9(2)(f)(iv) of the Official Information Act |
| 26/02/2026 | H2026078767 | Withheld under s9(2)(f)(iv) of the Official Information Act |
| 26/02/2026 | H2026079100 | Regulatory settings for medical devices |
| 26/02/2026 | H2026079123 | Withheld under s9(2)(f)(iv) of the Official Information Act |